Landos Biopharma
Why Robinhood?
You can watch LABP and buy or sell other stocks, ETFs, and their options commission-free!About LABP
Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of novel, oral, once-daily therapeutics for patients with certain immunology diseases. It offers NX-13, a novel, oral, gut-restricted compound for the treatment of inflammatory bowel disease, which targets the NLRX1 pathway.
LABP Key Statistics
Stock Snapshot
As of today, Landos Biopharma(LABP) shares are valued at $3.39. The company's market cap stands at 71.47M, with a P/E ratio of -5.74.
On 2026-03-31, Landos Biopharma(LABP) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Landos Biopharma(LABP) stock has reached 0.
Over the past 52 weeks, Landos Biopharma(LABP) stock has traded between a high of $22.94 and a low of $21.90.
Over the past 52 weeks, Landos Biopharma(LABP) stock has traded between a high of $22.94 and a low of $21.90.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.